行情

LGND

LGND

Ligand Pharma
NASDAQ

实时行情|Nasdaq Last Sale

72.27
+3.99
+5.84%
交易中 15:55 04/02 EDT
开盘
67.99
昨收
68.28
最高
76.19
最低
67.25
成交量
65.28万
成交额
--
52周最高
130.50
52周最低
57.24
市值
11.93亿
市盈率(TTM)
2.461
分时
5日
1月
3月
1年
5年

分析师评级

8位分析师的综合评级

买入

免责声明:分析师观点仅供投资者决策参考,不构成任何买卖投资建议。

目标价格预测

分析师预测LGND价格均价为186.00,最高价位237.00,最低价为134.00。

EPS

LGND 新闻

更多
  • 高盛警告最糟糕情况下 标普500指数成份股盈利或锐减57%
  • 新浪美股 · 4分钟前
  • 俄罗斯据称为今年20美元的油价做准备 将发行更多债券
  • 新浪美股 · 7分钟前
  • 黄金期货周四收高2.9% 5日来首次收高
  • 新浪美股 · 10分钟前
  • 60%的美国人认为经济"糟糕" 而1月份时67%认为经济"良好"
  • 新浪美股 · 21分钟前

所属板块

生物技术和医学研究
+2.74%
制药与医学研究
+2.51%

热门股票

代码
价格
涨跌幅

LGND 简况

Ligand Pharmaceuticals Incorporated (Ligand) is a biopharmaceutical company that focuses on developing and acquiring technologies that help pharmaceutical companies discover and develop medicines. The Company is involved in the development and licensing of biopharmaceutical assets. The Company employs research technologies, such as nuclear receptor assays, high throughput computer screening, formulation science, liver targeted pro-drug technologies and antibody discovery technologies to assist companies in their work toward obtaining prescription drug approvals. As of December 31, 2016, it had partnerships and license agreements with over 85 pharmaceutical and biotechnology companies, and over 140 various programs under license with it were in various stages of commercialization and development. It has contributed research and technologies for approved medicines that treat cancer, osteoporosis, fungal infections and low blood platelets, among others.
展开

微牛提供Ligand Pharmaceuticals Inc.(NASDAQ-LGND)的股票价格,实时市场报价,专业分析师评级,深度图表和免费的LGND股票新闻,以帮助您做出投资决策。